Welcome to our dedicated page for Hca Healthcare news (Ticker: HCA), a resource for investors and traders seeking the latest updates and insights on Hca Healthcare stock.
HCA Healthcare, Inc. (NYSE: HCA) is a Nashville-based provider of healthcare services with a network of 191 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers and physician clinics, in 20 states and the United Kingdom. This news page aggregates coverage related to HCA Healthcare’s operations, corporate actions and clinical and community initiatives.
Investors and observers following HCA Healthcare news can find updates on topics such as executive appointments, community engagement roles and leadership changes that shape the company’s strategic priorities. Recent announcements have included the naming of a chief nurse executive responsible for leading the nursing agenda across more than 100,000 nurses, and the appointment of a vice president of community engagement to oversee social and charitable investments, colleague giving, volunteering and nonprofit partnerships.
HCA Healthcare news also features information on public health and community-focused programs. Examples include the annual “Crush the Crisis” prescription drug take back day, where the company reports collecting tens of thousands of pounds of unused or expired medications since the initiative became an enterprise program, and philanthropic commitments through the HCA Healthcare Foundation and its Healthier Tomorrow Fund. Releases may highlight grants to organizations such as March of Dimes to support maternal and infant health campaigns, or gifts to universities to expand nursing education capacity.
Capital markets and investor-related updates, such as scheduled earnings conference calls and presentations at healthcare investment conferences, are also reflected in HCA Healthcare’s news flow. By reviewing these items together, readers can monitor how the company describes its clinical priorities, workforce initiatives, community partnerships and financial communications over time.
HCA Healthcare (NYSE: HCA) will present at the RBC Global Healthcare Conference on May 20, 2026 at 11:30am ET. A live audio webcast link and presentation materials will be posted in the Investor Relations section at www.hcahealthcare.com. Dates and times may change; check the IR site for updates.
HCA (NYSE: HCA) named Cynthia Cifuentes-Finkel senior vice president of marketing and corporate affairs, effective June 8, 2026. She will report to Mike McAlevey and lead enterprise marketing, corporate communications, and stakeholder engagement to support HCA’s growth priorities.
Cifuentes-Finkel brings 25+ years of leadership, including 15 years at Kaiser Permanente and experience overseeing a division serving nearly 5 million patients. She succeeds Deb Reiner, who retired after over 25 years of service.
HCA (NYSE: HCA) announced on April 27, 2026 that its subsidiary HCA Inc. proposes a public offering of senior notes, with final terms to be set at pricing. Net proceeds are planned for general corporate purposes, possibly repaying up to $4.000 billion of commercial paper and potentially redeeming up to $2.500 billion of near-term senior notes (5.250% due June 2026 and 5.375% due September 2026). Joint book-running managers are Citigroup, Barclays, BofA Securities and J.P. Morgan. The offering will be made via an effective shelf registration; details are in the preliminary prospectus supplement.
HCA Healthcare (NYSE: HCA) reported 1Q 2026 results: revenue $19.109B (+4.3%), net income $1.620B (+0.6%), and EPS $7.15 (+10.9%). Adjusted EBITDA was $3.802B (+1.9%).
Operating cash flow improved to $2.014B (+22.0%), share repurchases totaled $1.571B, dividend set at $0.78 per share, and 2026 guidance was reaffirmed.
HCA (NYSE:HCA) announced that 29 hospitals were named to Modern Healthcare’s 100 Top Hospitals Powered by Premier for 2026, with 7 hospitals receiving the Everest Award for sustained five‑year improvement.
Selection used objective CMS, MEDPAR and Medicare Cost Report data across 2,540 U.S. short‑term acute hospitals and highlights clinical, operational and patient experience performance.
HCA Healthcare (NYSE: HCA) will host its 1Q 2026 earnings conference call on Friday, April 24, 2026 at 9:00 AM Central (10:00 AM Eastern).
The event will be available as a live audio webcast and archived on the company investor website; investor and media contact names and phone numbers are provided for follow-up.
HCA Healthcare (NYSE:HCA) was named one of the 2026 World’s Most Ethical Companies by Ethisphere, marking its 16th recognition and placing it among four honorees in the Healthcare Providers and Services category. The award reflects documented ethics, compliance and governance practices evaluated by Ethisphere’s Ethics Quotient.
HCA highlighted 2025 community contributions: roughly $61.3M in giving, ~354,000 volunteer hours, $19.5M in colleague donations with matching, and $9.5M granted via the Hope Fund.
HCA Healthcare (NYSE:HCA) announced that 92 hospitals received the 2026 Healthgrades Patient Safety Excellence Award, recognizing the top 10% of U.S. hospitals for patient safety based exclusively on risk-adjusted outcomes.
The company highlighted decade-long operation of a federally listed Patient Safety Organization, 2024 implementation of the National Action Plan to Advance Patient Safety, and prior recognition of 44 HCA hospitals on Healthgrades America’s 250 Best Hospitals lists.
HCA Healthcare (NYSE: HCA) will present at multiple healthcare conferences in March 2026, with scheduled presentation dates and times listed by conference.
Live audio webcasts and presentation materials will be available in the Investor Relations section of the company website, www.hcahealthcare.com. Dates and times may change; check the conference schedule or the Investor Relations site for updates.
HCA Healthcare (NYSE:HCA) was named to Fortune’s 2026 World’s Most Admired Companies list and ranked No. 1 in its industry for the 12th consecutive year.
The company highlighted 2025 operational metrics: 54 research sites, > 6,600 patients enrolled across > 520 studies, > $40 million in tuition assistance to 11,700 colleagues, and > 9,200 Leadership Institute graduates in 2025.